Ridgetech, Inc.

About

Incorporated in 2025 with headquarters in Hangzhou, Ridgetech, Inc. is a rapidly growing, online and offline wholesale distributor of pharmaceutical and other healthcare products in China. Ridgetech actively trades on popular online distribution platforms nationwide and has its own online distribution platform. The Company believes that trading on these platforms offers greater opportunities to distribute pharmaceutical products nationwide. Ridgetech is a network technology company mainly engaged in B2B and new wholesale business of medicines, medical devices, health foods, cosmetics and daily necessities. The company has a professional sales team with service skills, and it has a well-established and high-quality sales network covering Zhejiang Province. Ridgetech’s business performance has been steadily improving year by year. As of December 2024, Ridgetech has more than 5000 varieties of products and proudly serves over 150,000 customers.

Verified company data

Shares outstanding

3,629,540

Leadership

Frank Ming Zhao (Chief Financial Officer, Mr. Zhao has served as our Chief Financial Officer since August 2011. He has extensive experience in financial consulting and auditing, having worked at CFO Oncall, Inc. and Sherb & Co., LLP. He is a licensed CPA and holds degrees in accounting from Central University of Finance and Economic and the University of Washington.), not discovered, not discovered

Verified data last updated: 2026-10-16

Recent filings

• Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19342025-03-03 · rdgt_2025-03-03_14-41-03.pdf→
• Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19342025-02-05 · rdgt_2025-02-05_08-00-00.pdf→
• Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19342025-02-03 · rdgt_2025-02-03_13-30-06.pdf→
• Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19342025-01-15 · rdgt_2025-01-15_14-00-34.pdf→
• [Amend] General statement of acquisition of beneficial ownership2024-11-14 · rdgt_2024-11-14_21-15-11.pdf→
• Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19342024-11-12 · rdgt_2024-11-12_21-15-03.pdf→
• Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19342024-10-21 · rdgt_2024-10-21_19-15-04.pdf→
• [Amend] General statement of acquisition of beneficial ownership2024-09-03 · rdgt_2024-09-03_11-50-20.pdf→